Mark Alvino

Mark Alvino has a diverse work experience spanning multiple industries. Mark served as President at Hudson Square Capital LLC. since 2012. In 2018, they founded Bridge Back Foundation, with a focus on addressing the opioid crisis in America through education, technology, and pharmaceutical options. Mark was also a Director at Abeona Therapeutics Inc., where they played key roles in the Audit and Compensation Committees, and at PlasmaTech Biopharmaceuticals, Inc. Additionally, Mark served as a Director at PainQx and a Principal at Advent CHC. Mark worked as a Business Director at M2 Productions LLC., overseeing the production and management of commercial theater. Mark was the Managing Director at Bradley Woods & Co. Ltd., a boutique research firm, and Griffin Securities. Mark also served as Managing Director at SCO Capital Partners LLC. Mark'searly career included the role of Senior Vice President at Feinstein Kean Healthcare.

Mark Alvino earned a Bachelor of Business Administration (BBA) degree from The George Washington University School of Business, specializing in Economics, Finance, and Public Policy. The degree was obtained between 1986 and 1991. In addition, they hold certifications in Series 7 and Series 63 obtained from FINRA, although the specific month and year of obtaining these certifications are not provided.